-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
![Aperture Bio team]()
-
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
![Day Zero team]()
-
GC Therapeutics
Using synthetic biology to program stem cells into any cell type with best-in-class efficiency, speed, and scalability.
![GC Therapeutics co-founders]()
-
Kinnos
Adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings.
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
![Manifold team]()
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
![Tectonic team]()
-
Transcera
Transforming chronic disease treatment through improved biologic drug delivery.
Take On the Challenge
Students: Apply for the PIC by Dec. 05.
